HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
C L Slingluff Selected Research
C L Slingluff Research Topics
Disease
11
Melanoma (Melanoma, Malignant)
01/2017 - 01/2000
7
Neoplasms (Cancer)
06/2001 - 03/2000
2
Neoplasm Metastasis (Metastasis)
10/2001 - 03/2001
1
Tetanus
10/2001
1
Lobular Carcinoma
06/2000
1
Margins of Excision
06/2000
1
Vaccinia
04/2000
Drug/Important Bio-Agent (IBA)
7
Peptides (Polypeptides)
IBA
11/2001 - 01/2000
5
Epitopes
IBA
11/2001 - 01/2000
4
Vaccines
IBA
10/2001 - 03/2000
3
HLA-A2 Antigen (HLA A2 Antigen)
IBA
06/2001 - 03/2000
3
HLA-A3 Antigen (HLA A3 Antigen)
IBA
06/2001 - 04/2000
2
Protein Subunit Vaccines
IBA
01/2017 - 06/2001
2
Antigens
IBA
11/2001 - 03/2000
2
gp100(280-288) melanoma antigen peptide
IBA
10/2001 - 06/2001
2
Monatide (IMS 3015)
IBA
10/2001 - 06/2001
2
Monophenol Monooxygenase (Tyrosinase)
IBA
06/2001 - 03/2000
2
gp100(17-25) peptide
IBA
06/2001 - 03/2001
2
HLA-A1 Antigen (HLA A1 Antigen)
IBA
06/2001 - 03/2000
2
Melanoma-Specific Antigens
IBA
03/2001 - 03/2000
2
Cancer Vaccines
IBA
03/2000 - 03/2000
1
saponin QA-21V1 (QS21)
IBA
10/2001
1
Tetanus Toxoid (Vaccine, Tetanus)
FDA Link
10/2001
1
Cytokines
IBA
10/2001
1
Immunologic Adjuvants (Immunologic Adjuvant)
IBA
10/2001
1
Emulsions
IBA
06/2001
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
06/2001
1
Neoplasm Antigens (Tumor Antigens)
IBA
03/2001
1
Interferon alpha-2 (Roferon-A)
FDA Link
02/2001
1
Proteins (Proteins, Gene)
FDA Link
03/2000
1
HLA-A Antigens (HLA-A)
IBA
03/2000
1
MART-1 Antigen
IBA
01/2000
Therapy/Procedure
2
Immunotherapy
04/2000 - 03/2000
1
Segmental Mastectomy (Lumpectomy)
06/2000